article thumbnail

FTC and DOJ Announce Workshops on the 2023 Draft Merger Guidelines

JD Supra: Mergers

The Federal Trade Commission (FTC) and Department of Justice (DOJ), Antitrust Division announced that they will hold three workshops regarding their jointly issued Draft Merger Guidelines. The first virtual workshop will be held on September 5, at 1-4:15 p.m. By: Troutman Pepper

Mergers 171
article thumbnail

FTC/DOJ Announce Three Public Workshops to Discuss the Draft Merger Guidelines

JD Supra: Mergers

Earlier this week, the Federal Trade Commission and the Department of Justice announced that they will be co-hosting three workshops to facilitate public dialogue on the recently issued draft Merger Guidelines. The first of these workshops will take place this coming Tuesday, September 5, from 1 p.m. to 4:15 p.m.

Mergers 159
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FTC Workshop Argues That Private Equity Incentives Are Not Aligned With Quality Health Care

JD Supra: Mergers

On March 5, the Federal Trade Commission (FTC) hosted a public workshop titled “Private Capital, Public Impact: An FTC Workshop on Private Equity in Health Care.” The event is part of the agency’s effort to publicize and encourage enforcement targeting private equity investments in health care.

article thumbnail

FTC and DOJ Antitrust Memorialize Joint Workshop on the Future of Antitrust Enforcement in the Pharmaceutical Industry

JD Supra: Mergers

Department of Justice Antitrust Division, recently released a summary of the Agencies’ June 2022 joint workshop titled “The Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers.” By: Mintz

article thumbnail

Newly Finalized FTC/DOJ Merger Guidelines Are Likely to Increase Antitrust Scrutiny of M&A Deals - Health Care and Private Equity Transactions May See Significant Impact

JD Supra: Mergers

Earlier this week, the Department of Justice (“DOJ”) and Federal Trade Commission (“FTC”) released the long-awaited 2023 Merger Guidelines. The final guidelines are the result of nearly two years of behind-the-scenes drafting, numerous public listening sessions and workshops, and the receipt of some 35,000 public comments.

article thumbnail

FTC and DOJ officials offer additional commentary on draft merger guidelines

JD Supra: Mergers

On September 5, 2023 the Federal Trade Commission (FTC) and Department of Justice (DOJ) (the Agencies) hosted the first of three planned workshops intended to “facilitate public dialogue” on the 2023 FTC and DOJ Draft Merger Guidelines (the draft guidelines). If adopted, the guidelines would memorialize the Agencies’.

Mergers 165
article thumbnail

FTC and DOJ outline potential changes to agencies’ review of pharmaceutical mergers

JD Supra: Mergers

On June 1, 2023, the Federal Trade Commission (FTC) and the Antitrust Division of the US Department of Justice (DOJ) released a summary of a workshop jointly held by the agencies in June 2022 titled “Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers.”